Parametric Portfolio Associates’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.06M | Buy |
111,362
+33,111
| +42% | +$315K | ﹤0.01% | 2757 |
|
|
2021
Q4 | $1.49M | Sell |
78,251
-504
| -0.6% | -$9.58K | ﹤0.01% | 2616 |
|
|
2021
Q3 | $2.62M | Sell |
78,755
-53,045
| -40% | -$1.77M | ﹤0.01% | 2280 |
|
|
2021
Q2 | $5.11M | Sell |
131,800
-15,078
| -10% | -$585K | ﹤0.01% | 1843 |
|
|
2021
Q1 | $7.08M | Buy |
146,878
+3,622
| +3% | +$175K | ﹤0.01% | 1921 |
|
|
2020
Q4 | $7.45M | Buy |
143,256
+1,990
| +1% | +$104K | ﹤0.01% | 1802 |
|
|
2020
Q3 | $3.78M | Buy |
141,266
+5,016
| +4% | +$134K | ﹤0.01% | 2091 |
|
|
2020
Q2 | $2.65M | Buy |
136,250
+94,139
| +224% | +$1.83M | ﹤0.01% | 2323 |
|
|
2020
Q1 | $414K | Buy |
42,111
+3,516
| +9% | +$34.6K | ﹤0.01% | 3265 |
|
|
2019
Q4 | $428K | Buy |
38,595
+18,956
| +97% | +$210K | ﹤0.01% | 3430 |
|
|
2019
Q3 | $110K | Sell |
19,639
-1,513
| -7% | -$8.47K | ﹤0.01% | 3819 |
|
|
2019
Q2 | $183K | Buy |
21,152
+6,609
| +45% | +$57.2K | ﹤0.01% | 3758 |
|
|
2019
Q1 | $117K | Buy |
+14,543
| New | +$117K | ﹤0.01% | 3799 |
|
|
2017
Q4 | – | Sell |
-85,622
| Closed | -$1.02M | – | 3941 |
|
|
2017
Q3 | $1.02M | Buy |
85,622
+146
| +0.2% | +$1.73K | ﹤0.01% | 3034 |
|
|
2017
Q2 | $859K | Buy |
85,476
+5,822
| +7% | +$58.5K | ﹤0.01% | 3064 |
|
|
2017
Q1 | $928K | Buy |
+79,654
| New | +$928K | ﹤0.01% | 2902 |
|
|
2016
Q1 | – | Sell |
-13,955
| Closed | -$166K | – | 4023 |
|
|
2015
Q4 | $166K | Sell |
13,955
-1,663
| -11% | -$19.8K | ﹤0.01% | 3773 |
|
|
2015
Q3 | $157K | Sell |
15,618
-18,190
| -54% | -$183K | ﹤0.01% | 3131 |
|
|
2015
Q2 | $561K | Buy |
+33,808
| New | +$561K | ﹤0.01% | 3208 |
|